Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Xiidra (lifitegrast) and Rhopressa (netarsudil) are both prescription eye drop medications, but they treat different conditions. Xiidra is used to treat dry eyes. It is an LFA-1 (lymphocyte function-associated antigen-1) antagonist, which helps reduce inflammation in the eyes. On the other hand, Rhopressa is used to lower eye pressure in people with glaucoma or ocular hypertension. It is a ROCK (rho kinase) inhibitor, which helps drain fluid from the eye. Xiidra is typically applied twice daily, while Rhopressa is used once daily at night. Xiidra and Rhopressa are only available as a brand name medication. Common side effects of Xiidra include eye irritation and blurry vision, while Rhopressa often causes eye redness and cornea deposits.
Xiidra (lifitegrast)
Rhopressa (netarsudil)
Xiidra (lifitegrast)
Rhopressa (netarsudil)
Summary of Xiidra vs. Rhopressa
Summary for LFA-1 antagonist
Prescription only
Xiidra (lifitegrast) is an eye drop medication that treats dry eye. Typically, you apply one drop two times every day. Common side effects of Xiidra (lifitegrast) can include temporary eye irritation and unclear vision after using the eye drops. At this time, Xiidra (lifitegrast) is available only as a brand medication; there's no generic version yet.
Summary for ROCK inhibitor
Prescription only
Rhopressa, also known by its generic name, netarsudil, is an eye drop medication used to lower eye pressure in people with glaucoma or ocular hypertension. It received FDA approval in December 2017 and belongs to a newer class of medications called ROCK (rho kinase) inhibitors. The medication is given as a drop into the affected eye(s) once every night. Common side effects include eye redness and blurry vision.